Comparative genomics between matched solid and lepidic portions of semi-solid lung adenocarcinomas

Authors: Woodard, Gavitt A., Ding, Vivianne, Cho, Christina, Brand, Nathan R., Kratz, Johannes R., Jones, Kirk D., Jablons, David M.

Source: In Lung Cancer June 2023 180

SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants

Authors: Hysenaj, Lisiena, Little, Samantha, Kulhanek, Kayla, Magnen, Melia, Bahl, Kriti, Gbenedio, Oghenekevwe M., Prinz, Morgan, Rodriguez, Lauren, Andersen, Christopher, Rao, Arjun Arkal, Shen, Alan, Lone, Jean-Christophe, Lupin-Jimenez, Leonard C., Bonser, Luke R., Serwas, Nina K., Mick, Eran, Khalid, Mir M., Taha, Taha Y., Kumar, Renuka, Li, Jack Z., Ding, Vivianne W., Matsumoto, Shotaro, Maishan, Mazharul, Sreekumar, Bharath, Simoneau, Camille, Nazarenko, Irina, Tomlinson, Michael G., Khan, Khajida, von Gottberg, Anne, Sigal, Alex, Looney, Mark R., Fragiadakis, Gabriela K., Jablons, David M., Langelier, Charles R., Matthay, Michael, Krummel, Matthew, Erle, David J., Combes, Alexis J., Sil, Anita, Ott, Melanie, Kratz, Johannes R., Roose, Jeroen P.

Source: In Stem Cell Reports 14 March 2023 18(3):636-653

A Perspective on the MARS2 Trial.

Authors: Lim, Eric, Opitz, Isabelle, Woodard, Gavitt, Bueno, Raphael, de Perrot, Marc, Flores, Raja, Gill, Ritu, Jablons, David, Pass, Harvey

Source: Journal of Thoracic Oncology; Mar2025, Vol. 20 Issue 3, p262-272, 11p

Discovering dominant tumor immune archetypes in a pan-cancer census

Authors: Spitzer, Matthew, Fong, Lawrence, Nelson, Amanda, Kumar, Raj, Lee, Justin, Burra, Arun, Hsu, Joy, Hackett, Caroline, Tolentino, Karen, Sjarif, Jasmine, Johnson, Peter, Shao, Evans, Abrau, Darrell, Lupin, Leonard, Shaw, Cole, Collins, Zachary, Lea, Tasha, Corvera, Carlos, Nakakura, Eric, Carnevale, Julia, Alvarado, Michael, Loo, Kimberley, Chen, Lawrence, Chow, Melissa, Grandis, Jennifer, Ryan, Will, El-Sayed, Ivan, Jablons, David, Woodard, Gavitt, Meng, Maxwell W., Porten, Sima P., Okada, Hideho, Tempero, Margaret, Ko, Andrew, Kirkwood, Kim, Vandenberg, Scott, Guevarra, Denise, Oropeza, Erica, Cyr, Chris, Glenn, Pat, Bolen, Jennifer, Morton, Amanda, Eckalbar, Walter, Combes, Alexis J., Samad, Bushra, Tsui, Jessica, Chew, Nayvin W., Yan, Peter, Reeder, Gabriella C., Kushnoor, Divyashree, Shen, Alan, Davidson, Brittany, Barczak, Andrea J., Adkisson, Michael, Edwards, Austin, Naser, Mohammad, Barry, Kevin C., Courau, Tristan, Hammoudi, Taymour, Argüello, Rafael J., Rao, Arjun Arkal, Olshen, Adam B., Cai, Cathy, Zhan, Jenny, Davis, Katelyn C., Kelley, Robin K., Chapman, Jocelyn S., Atreya, Chloe E., Patel, Amar, Daud, Adil I., Ha, Patrick, Diaz, Aaron A., Kratz, Johannes R., Collisson, Eric A., Fragiadakis, Gabriela K., Erle, David J., Boissonnas, Alexandre, Asthana, Saurabh, Chan, Vincent, Krummel, Matthew F.

Source: In Cell 6 January 2022 185(1):184-203

Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non–Squamous Non–Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit From Adjuvant Chemotherapy

Authors: Woodard, Gavitt A., Kratz, Johannes R., Haro, Greg, Gubens, Matthew A., Blakely, Collin M., Jones, Kirk D., Mann, Michael J., Jablons, David M.

Source: In Clinical Lung Cancer November 2021 22(6):587-595

Development of novel monoclonal antibodies and immunoassays for sensitive and specific detection of SULF1 endosulfatase

Authors: Yang, Yi-Wei, Phillips, Joanna J., Jablons, David M., Lemjabbar-Alaoui, Hassan

Source: In BBA - General Subjects February 2021 1865(2)

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing

Authors: Maynard, Ashley, McCoach, Caroline E., Rotow, Julia K., Harris, Lincoln, Haderk, Franziska, Kerr, D. Lucas, Yu, Elizabeth A., Schenk, Erin L., Tan, Weilun, Zee, Alexander, Tan, Michelle, Gui, Philippe, Lea, Tasha, Wu, Wei, Urisman, Anatoly, Jones, Kirk, Sit, Rene, Kolli, Pallav K., Seeley, Eric, Gesthalter, Yaron, Le, Daniel D., Yamauchi, Kevin A., Naeger, David M., Bandyopadhyay, Sourav, Shah, Khyati, Cech, Lauren, Thomas, Nicholas J., Gupta, Anshal, Gonzalez, Mayra, Do, Hien, Tan, Lisa, Bacaltos, Bianca, Gomez-Sjoberg, Rafael, Gubens, Matthew, Jahan, Thierry, Kratz, Johannes R., Jablons, David, Neff, Norma, Doebele, Robert C., Weissman, Jonathan, Blakely, Collin M., Darmanis, Spyros, Bivona, Trever G.

Source: In Cell 3 September 2020 182(5):1232-1251

The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region

Alternate Title: EDITORS' PICK: Structure of HIPK2 bound to CX-4945 (English)

Authors: Agnew, Christopher, Liu, Lijun, Liu, Shu, Xu, Wei, You, Liang, Yeung, Wayland, Kannan, Natarajan, Jablons, David, Jura, Natalia

Source: In Journal of Biological Chemistry 13 September 2019 294(37):13545-13559

Incorporation of a Molecular Prognostic Classifier Improves Conventional Non–Small Cell Lung Cancer Staging

Authors: Kratz, Johannes R., Haro, Greg J., Cook, Nancy R., He, Jianxing, Van Den Eeden, Stephen K., Woodard, Gavitt A., Gubens, Matthew A., Jahan, Thierry M., Jones, Kirk D., Kim, Il-Jin, He, Biao, Jablons, David M., Mann, Michael J.

Source: In Journal of Thoracic Oncology July 2019 14(7):1223-1232

Scientific Advances and New Frontiers in Mesothelioma Therapeutics

Authors: Mutti, Luciano, Peikert, Tobias, Robinson, Bruce W.S., Scherpereel, Arnaud, Tsao, Anne S., de Perrot, Marc, Woodard, Gavitt A., Jablons, David M., Wiens, Jacinta, Hirsch, Fred R., Yang, Haining, Carbone, Michele, Thomas, Anish, Hassan, Raffit

Source: In Journal of Thoracic Oncology September 2018 13(9):1269-1283

Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non–Small-Cell Lung Cancer

Authors: Woodard, Gavitt A., Wang, Sue X., Kratz, Johannes R., Zoon-Besselink, Clara T., Chiang, Chun-Yuan, Gubens, Matthew A., Jahan, Thierry M., Blakely, Collin M., Jones, Kirk D., Mann, Michael J., Jablons, David M.

Source: In Clinical Lung Cancer January 2018 19(1):58-64

SOCS-3 Is Frequently Silenced by Hypermethylation and Suppresses Cell Growth in Human Lung Cancer

Authors: He, Biao, You, Liang, Uematsu, Kazutsugu, Zang, Keling, Xu, Zhidong, Lee, Amie Y., Costello, Joseph F., McCormick, Frank, Jablons, David M.

Source: Proceedings of the National Academy of Sciences of the United States of America, 2003 Nov . 100(24), 14133-14138.

Access URL: https://www.jstor.org/stable/3148924

Management of Lung Cancer Invading the Superior Sulcus

Authors: Kratz, Johannes R., Woodard, Gavitt, Jablons, David M.

Source: In Thoracic Surgery Clinics May 2017 27(2):149-157

Operative and Perioperative Pulmonary Emboli

Authors: Cox, Jordy C., Jablons, David M.

Source: In Thoracic Surgery Clinics August 2015 25(3):289-299

Transforming Growth Factor-β and Interleukin-1β Signaling Pathways Converge on the Chemokine CCL20 Promoter

Authors: Brand, Oliver J., Somanath, Sangeeta, Moermans, Catherine, Yanagisawa, Haruhiko, Hashimoto, Mitsuo, Cambier, Stephanie, Markovics, Jennifer, Bondesson, Andrew J., Hill, Arthur, Jablons, David, Wolters, Paul, Lou, Jianlong, Marks, James D., Baron, Jody L., Nishimura, Stephen L.

Source: In Journal of Biological Chemistry 5 June 2015 290(23):14717-14728

NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer

Authors: Blakely, Collin M., Pazarentzos, Evangelos, Olivas, Victor, Asthana, Saurabh, Yan, Jenny Jiacheng, Tan, Irena, Hrustanovic, Gorjan, Chan, Elton, Lin, Luping, Neel, Dana S., Newton, William, Bobb, Kathryn L., Fouts, Timothy R., Meshulam, Jeffrey, Gubens, Matthew A., Jablons, David M., Johnson, Jeffrey R., Bandyopadhyay, Sourav, Krogan, Nevan J., Bivona, Trever G.

Source: In Cell Reports 7 April 2015 11(1):98-110

Extracellular sulfatases as potential blood-based biomarkers for early detection of lung cancer.

Authors: Yang, Yi-Wei¹ (AUTHOR), Jablons, David M.¹ (AUTHOR), Lemjabbar-Alaoui, Hassan¹ (AUTHOR)

Source: Experimental Lung Research. Jul-Aug2021, Vol. 47 Issue 6, p261-279. 19p.

Subject Terms: *EARLY detection of cancer, *SULFATASES, *BIOMARKERS, *PLASMA potentials, *BLOOD proteins

Prognostic Molecular Assay Might Improve Identification of Patients At Risk for Recurrence in Early-Stage Non–Small-Cell Lung Cancer

Authors: Woodard, Gavitt A., Gubens, Matthew A., Jahan, Thierry M., Jones, Kirk D., Kukreja, Jasleen, Theodore, Pierre R., Cardozo, Shayne, Jew, Gregory, Clary-Macy, Carolyn, Jablons, David M., Mann, Michael J.

Source: In Clinical Lung Cancer November 2014 15(6):426-432

The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma

Authors: Giroux Leprieur, Etienne, Hirata, Tomomi, Mo, Minli, Chen, Zhao, Okamoto, Junichi, Clement, Genevieve, Li, Hui, Wislez, Marie, Jablons, David M., He, Biao

Source: In Lung Cancer September 2014 85(3):465-471

Shades of Gray: Do Never Smokers Benefit From Lung Cancer Screening Programs?

Authors: Woodard, Gavitt A., Jablons, David M.

Source: Journal of Thoracic Oncology; Aug2024, Vol. 19 Issue 8, p1135-1137, 3p